Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Schoppmann, SF; Bayer, G; Aumayr, K; Taucher, S; Geleff, S; Rudas, M; Kubista, E; Hausmaninger, H; Samonigg, H; Gnant, M; Jakesz, R; Horvat, R; Ann Surg. 2004; 240(2):306-312

[Systemic ALlambda amyloidosis associated with vascular fragility].

Laimer, M; Kaindl, K; Emberger, M; Hawranek, T; Lanschützer, CM; Bauer, JW; Linke, RP; Mlineritsch, B; Hintner, H; J Dtsch Dermatol Ges. 2004; 2(11): 934-939.

Biomarkers in non-small cell lung cancer prevention.

Hilbe, W; Dirnhofer, S; Greil, R; Wöll, E; Eur J Cancer Prev. 2004; 13(5):425-436

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1

Johrer, K; Janke, K; Krugmann, J; Fiegl, M; Greil, R CLIN CANCER RES. 2004; 10(6): 1901-1910.

Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis

Steurer, M; Pall, G; Richards, S; Schwarzer, G; Bohlius, J; Greil, R ANN ONCOL. 2005; 16: 203-204.

Expression levels of CD38 in tumor cells and T-cells are of prognostic value in B-CLL

Tinhofer, I; Rubenzer, G; Egle, A; Greil, R BLOOD. 2005; 106(11): 347A-347A.

Recent interim analysis of the HD11 trial of the GHSG: intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin’s lymphoma.

Diehl, V; Brillant, C; Engert, A; Mueller, RP; Eich, HT; Mueller-Hermelink, K; Herrmann, R; Markova, J; Ho, A; Hiddemann, W; Doerken, B; Greil, R; Josting, A; Pfistner, B; Blood. 2005; 106(11):816–47th Annual Meeting of the American Society of Hematology (ASH); 10.-13.12.2005; Atlanta, Georgia.

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Engert, A; Pluetschow, A; Eich, HT; Herrmann, R; Doerken, B; Kanz, L; Greil, R; Markova, J; Pfistner, B; Josting, A; Mueller-Hermelink, K; Mueller, RP; Diehl, V; Blood. 2005; 106(11):2673–47th Annual Meeting of the American Society of Hematology (ASH); 10.-13.12.2005; Atlanta, Georgia.

Alemtuzumab is effective in patients with advanced, pretreated B-cell chronic lymphocytic leukemia: A nationwide study of routine use in Austria

Fiegl, M; Falkner, A; Hopfinger, G; Brugger, S; Zabernigg, A; Haslbauer, F; Andel, J; Thaler, J; Fridrik, M; Bauer, F; Mian, M; Tatzreiter, G; Zoier, N; Demirtas, D; Postner, G; Auberger, J; Gastl, G; Greil, R BLOOD. 2005; 106(11): 833A-833A.

Chemotherapie im Alter

Greil, R; Faber, V; In: Likar, R; Bernatzky, G; Pipam, W; Janig, H; Sadjak, A;_x000D_ _x000D_ editors(s). Lebensqualität im Alter. Springer; p. 257-264. (ISBN: 978-3-211-21197-7)